Long-term data on ambulatory monitoring patches. Scientists from the Scripps Research Translational Institute and Johnson & Johnson have unveiled three-year study data for iRhythm Technologies' Zio wearable ambulatory monitoring patches at this year's American Heart Association Scientific Sessions. The mSToPS study examined 1,738 participants who were a mean age 73.7 years at the time of...
According to a new study published this morning in Nature, an algorithm trained via a deep neural network has been able to perform on par with board-certified cardiologists at the annotation of 12 different types of heart rhythms.
Researchers from Stanford University and iRhythm collaborated for the study, which detailed an algorithm trained on 91,232 30-second single-lead ECG readings from 53,...
iRhythm Technologies reported a promising second quarter from a financial standpoint, citing a revenue of $35.5 million, up 55 percent from this time last year. But CEO Kevin King's major focus on the call was not earnings, but a pair of scientific studies published last month in the Journal of the American Medical Association and JAMA Cardiology.
These studies and what they represent could crack...
A take-home wearable ECG could be key in detecting undiagnosed atrial fibrillation, according to a new study published in JAMA this morning. Researchers from The Scripps Research Institute used the iRhythm Zio patch, an ECG screening wearable, to monitor patients with a risk for the condition.
Researchers discovered that patients who immediately began monitoring were significantly more likely to...
Connected wearable patch makers will ship 35.1 million units annually by 2022, with 80 percent of these being used in clinical applications, according to a recent report from market intelligence firm Tractica.
The report also forecasts a total $7.9 billion in revenue for the patch market by the same year, all of which suggests a substantial escalation from the 966,000 units the analysts wrote...
A team of researchers from Stanford University, working with cardiac monitoring company iRhythm, have created an AI algorithm that, in a small proof-of-concept trial, outperformed board-certified cardiologists at identifying various types of arrhythmias from ECGs. The results have been published to arXiv, an online archive for scientific papers, but have not yet appeared in a peer-reviewed...
iRhythm, maker of the wearable-and-wireless-but-not-connected Zio heart rate monitoring system, has filed with the SEC to raise up to $86 million in an initial public offering.
The Zio patch, iRhythm's sole product as of now, is a small wearable sensor, used for multi-day monitoring of arrhythmias in cardiac patients (up to a fortnight). Unlike many participants in that space, however, the...
iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture Partners also participated in the round. This brings the company's total disclosed funding to about $85 million, based on SEC filings and company announcements. As part of the latest investment deal...
Tel Aviv, Israel-based HealthWatch is working on another entry for the still emerging smart textile field. At the American Telemedicine Association conference in Baltimore, Maryland, the startup previewed its hWear line of tshirts with interwoven ECG sensors, allowing the shirt to function as a 3 to 15 lead ECG.
"A cardiologist will not formally diagnose a heart attack until you’ve taken a 12-...
August is not yet half over and already the FDA has had a busy summer.
In recent weeks MobiHealthNews reported on the FDA's de novo clearance of Proteus Digital Health's intelligent medicine platform and Asthmapolis' inhaler sensor and companion software. As we noted early last month, the FDA granted 510(k) clearance to a variety of digital health companies in June, including the app-enabled...
